Modular Laboratory Automation Market By Product Type (Robotic Arms, Liquid Handling Systems, Automated Storage Modules, Integrated Software Platforms); By Application (Drug Discovery, Clinical Diagnostics, Genomics & Proteomics, Microbiology, Food & Environmental Testing); By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Academic & Research Institutions, Food & Environmental Testing Facilities); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Modular Laboratory Automation Market: Flexible Systems Improve Laboratory Throughput and Workflow Control

The Global Modular Laboratory Automation Market was valued at USD 3.35 billion in 2025 and is projected to reach USD 5.27 billion by 2032, expanding at a CAGR of 6.7% during 2026–2032.

 

Modular laboratory automation is based on self-contained and standardized hardware and software units such as robotic liquid handlers, decappers, and analytical stations. These units are designed so they can be independently added, removed, or reconfigured depending on laboratory requirements. Demand for this approach is increasing because laboratories need flexible scalability, lower initial investment compared to rigid monolithic systems, and higher overall testing throughput.

 

The growing demand for modular laboratory automation is driven by several factors. One of the most important is affordability, as traditional full-scale laboratory automation systems often require very high upfront investment and fixed infrastructure layouts. Modular systems reduce this barrier by allowing laboratories to automate selectively within more manageable budgets. Increasing workloads in clinical diagnostics, genomics, and pharmaceutical research are also contributing to adoption, as laboratories must process larger sample volumes while facing shortages of skilled personnel. This has increased the need for continuous, error-free, and high-throughput operations.

 

Liquid Handling Remains the Core Product Category

Liquid handling systems led the market with a 34.0% share in 2025, driven by their essential role in pharmaceutical research, diagnostics, genomics, and microbiology. Automated pipetting improves accuracy, reduces variation, and increases sample throughput, making it widely used across pharma, biotech, and academic labs. Adoption is strong among major pharmaceutical companies such as Pfizer, Roche, Novartis, and AstraZeneca, which use these systems for compound screening and assay preparation. Biotechnology firms like Moderna and Amgen also rely on them for high-volume workflows, while research centers such as the Broad Institute use them for large-scale genomics studies.

 

Robotic arms accounted for 24.0% of the market (USD 0.80 billion in 2025) and are expected to grow at 7.2% CAGR. They move samples between instruments like liquid handlers, incubators, and readers, enabling continuous automated workflows. Demand is rising in high-throughput environments such as Johnson & Johnson and Merck R&D facilities, where they support screening and testing operations. Contract research organizations like Labcorp Drug Development also use robotic systems to handle large, multi-client testing volumes efficiently.

 

Integrated software platforms generated USD 0.80 billion in 2025, representing a 24.0% share, and are the fastest-growing segment at 7.4% CAGR. These systems manage scheduling, sample tracking, audit trails, and instrument coordination while improving connectivity across laboratory devices. Standards like SiLA 2 support interoperability between systems. Companies such as Thermo Fisher Scientific, Agilent Technologies, and Tecan provide integrated software solutions, while diagnostic leaders like Quest Diagnostics and Labcorp use them to ensure traceability, compliance, and real-time workflow monitoring across multiple sites.

 

Automated storage systems held an 18.0% share (USD 0.60 billion in 2025) and grow at a slower 6.0% CAGR due to high infrastructure and validation costs. Demand is mainly driven by biobanks and large research facilities. For example, UK Biobank is expanding capacity to manage up to 20 million samples, up from its current 10 million-sample automated system. Similar large-scale storage investments are seen at companies like AstraZeneca and Novartis, which use automated freezer systems to store and manage millions of research and compound samples under controlled conditions.

 

Drug Discovery Generates the Largest Application Revenue

Drug discovery remained the largest application, accounting for 29.0% of market revenue (USD 0.97 billion in 2025). Pharmaceutical laboratories depend on automation for routine tasks such as assay preparation, compound screening, and sample movement between storage and analysis systems. Because workflows often shift between screening, cell-based studies, and protein analysis, demand is strongest for flexible systems that can be quickly reconfigured for different experiments.

 

Pharmaceutical and biotechnology companies also formed the largest end-user group, holding a 38.0% share (USD 1.27 billion in 2025) and expected to grow at a 7.0% CAGR. Growth is driven by the need for higher throughput, better reproducibility, and faster drug development timelines. Supporting this trend, Novartis announced a USD 1.1 billion biomedical research hub in San Diego (2025), reflecting increased investment in automated and AI-enabled laboratory design. Companies such as Merck (MSD) and Johnson & Johnson are also expanding automated discovery platforms across their R&D networks to improve consistency and reduce early-stage development time.

 

Genomics and Proteomics Record the Fastest Application Growth

Genomics and proteomics accounted for 20.0% of the market (USD 0.67 billion in 2025) and are expected to grow at 7.7%, the fastest among applications. Growth is driven by high-throughput sequencing workflows that involve repeated steps such as extraction, purification, quantification, and library preparation, where even small errors can impact results. Modular automation is widely used in these workflows because it allows laboratories to scale sample preparation and add new sequencing platforms without redesigning the full system. This is especially important for research institutes, clinical genomics labs, and biotech firms handling large and variable sample volumes.

 

Companies such as Illumina, Eurofins Genomics, and BGI Genomics use automated liquid handling systems to manage high-throughput sequencing operations, while Thermo Fisher Scientific and Beckman Coulter Life Sciences provide integrated platforms for library preparation and nucleic acid processing.

 

Demand is also supported by large-scale national and commercial genomics programs. For example, India’s GenomeIndia initiative released data from 10,000 whole-genome samples in 2025, increasing the need for standardized and automated sample processing across research centers. In Singapore, ChemLex raised USD 45 million in 2025 to build a self-driving drug discovery lab combining automated synthesis and continuous experimentation, highlighting the growing use of robotics and software in genomics-driven research environments.

 

Clinical Diagnostics Prioritizes Reliability and Traceability

Clinical diagnostics accounted for 27.0% of application revenue, or USD 0.90 billion in 2025, and also represented 27.0% of end-user demand, driven by hospitals and diagnostic laboratories such as Quest Diagnostics, Labcorp, Mayo Clinic Laboratories, Sonic Healthcare, and Eurofins Clinical Diagnostics. These facilities prioritize fast turnaround times, high uptime, sample traceability, and consistent test accuracy. Because diagnostic workflows are highly validated, they change less frequently, making modular automation useful for scaling specific testing areas without replacing entire systems.

 

Regulatory frameworks such as FDA 21 CFR Part 11 and the EU IVDR further reinforce the need for secure electronic records, audit trails, and validated workflows, increasing demand for compliant software and limiting frequent system changes once processes are validated.

 

Smaller Testing Applications Favor Selective Automation

Microbiology accounted for 13.0% of the market (USD 0.44 billion in 2025), while food and environmental testing made up 11.0% (USD 0.37 billion). Together, these labs rely more on flexible automation than full robotic systems due to varied sample types and changing test methods. Most adoption focuses on core steps such as dilution, aliquoting, extraction, plating, and sample transfer. For example, bioMérieux provides automated microbiology platforms used in clinical and industrial labs for pathogen detection, while Thermo Fisher Scientific supplies automated sample preparation and plating systems widely used in food safety testing laboratories. Companies such as Agilent Technologies also support environmental testing labs with automated extraction and analytical workflows that improve consistency and throughput.

 

Food and environmental testing also represented 14.0% of end-user revenue (USD 0.47 billion) and is expected to grow at a slower 5.9% CAGR, as demand is closely tied to contract volumes and lab budgets. Compliance with ISO/IEC 17025 continues to support automation adoption by requiring consistent, traceable, and repeatable testing processes, encouraging investment in targeted automation where sample volumes justify it.

 

Asia-Pacific Expands Faster Than Mature Regions

North America led the market with a 37.0% share and USD 1.24 billion in 2025. The region benefits from large pharmaceutical research operations, national diagnostic networks, established laboratory automation companies and extensive technical-service coverage. Demand is strongly supported by companies such as Thermo Fisher Scientific, Danaher (Beckman Coulter Life Sciences), Agilent Technologies, and PerkinElmer, which supply integrated liquid handling, robotic systems and workflow software to pharmaceutical and clinical laboratories. Large diagnostic networks such as Quest Diagnostics and Labcorp also continue to expand automated testing capacity to improve turnaround time and sample traceability.

 

Europe accounted for 27.0% of the market, or USD 0.90 billion, and is forecast to grow at 6.0%. Pharmaceutical research, diagnostics and biobanking remain important demand areas. Growth is more moderate because many laboratories already use some form of automation and regulated workflows require lengthy validation. Demand is supported by companies such as Roche Diagnostics, Siemens Healthineers, Sartorius, and Tecan Group, which provide modular automation platforms widely used in clinical laboratories, academic research institutes and biobanks across Germany, Switzerland, the UK and France.

 

Asia-Pacific held a 26.0% share, equal to USD 0.87 billion, but is forecast to record the fastest regional CAGR at 8.2%. New biotechnology facilities, national genomics programmes and automation-led research projects are creating new capacity. Regional growth is therefore more closely linked to new laboratory construction and workflow expansion than to replacement activity. Demand is being driven by expanding operations of companies such as BGI Genomics in China, MedGenome in India, and Sysmex in Japan, along with global players like Thermo Fisher Scientific and Hamilton Company, which are supplying automated sample preparation and sequencing workflow systems for large-scale genomics and drug discovery projects.

 

Latin America represented 6.0% of the market, while the Middle East and Africa accounted for 4.0%. Adoption is concentrated in reference laboratories, private diagnostic networks, national research centres and larger food-testing facilities. Compact liquid-handling systems are likely to remain the main entry point because technical-service access and capital availability are more limited. Demand in these regions is supported by diagnostic and laboratory service providers such as DASA (Diagnósticos da América) in Brazil, FLEURY Group, and Ampath in South Africa, which are gradually introducing automation to improve testing efficiency and standardization in high-volume clinical laboratories.

 

Leading Company Profiles in the Modular Laboratory Automation Market

Competition is shifting from individual equipment performance toward complete workflow control.

 

Tecan offers modular liquid handling and automation platforms such as the Fluent and Freedom EVO systems, along with the newer Veya workstation. Its portfolio also includes integrated robotics, assay-ready workstations and workflow management software for sample processing and screening applications.

 

Beckman Coulter Life Sciences focuses on the Biomek series of automated liquid handlers, including the Biomek i-Series. The company also provides integrated workcells, plate handling systems and software tools designed for high-throughput sample preparation and reproducible assay workflows.

 

Hamilton Company supplies precision liquid handling systems such as the Microlab STAR and VANTAGE platforms. Its portfolio extends to robotic pipetting systems, automated storage integration, and configurable workstations used in genomics, diagnostics and pharmaceutical research.

 

Thermo Fisher Scientific offers automation solutions including KingFisher purification systems, automated liquid handlers and integrated robotic platforms. Its portfolio also includes sample preparation systems, laboratory workflow software and connected instruments used across clinical and research laboratories.

 

Agilent Technologies provides automated liquid handling systems such as the Bravo platform and BenchCel workstations. The company also supplies plate management systems, robotic integration tools and software for method development and laboratory workflow automation.

 

Azenta Life Sciences specializes in automated sample management and storage systems, including ultra-low temperature biobanking platforms. Its portfolio includes robotic sample retrieval systems, compound storage solutions and digital tracking software for large-scale biological sample libraries.

 

Specialist software companies focus on laboratory connectivity and workflow orchestration. Their offerings include middleware based on standards such as SiLA 2, laboratory information management system (LIMS) integration tools, and platforms that enable coordination between instruments, data systems and automated workcells.

 

Modular Laboratory Automation Market Report Coverage Table

Report Attribute	Details
Forecast Period	2026–2032
Market Size Value in 2025	USD 3.35 Billion
Revenue Forecast in 2032	USD 5.27 Billion
Overall Growth Rate	CAGR of 6.7% (2026–2032)
Base Year for Estimation	2025
Historical Data	2019–2024
Unit	USD Million, CAGR (2026–2032)
Segmentation	By Product Type, By Application, By End User, By Geography
By Product Type	Robotic Arms, Liquid Handling Systems, Automated Storage Modules, Integrated Software Platforms
By Application	Drug Discovery, Clinical Diagnostics, Genomics & Proteomics, Microbiology, Food & Environmental Testing
By End User	Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Academic & Research Institutions, Food & Environmental Testing Facilities
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Market Drivers	Flexible scalability and lower initial investment Rising sample volumes in drug discovery and clinical diagnostics Shortages of skilled laboratory personnel
Customization Option	Available upon request